Fauci Awards Package (Redacted) — page 56

From: "Mascola, John (NIH/VRC) [E]" < @mail.nih.gov> To: "Erbelding, Emily (NIH/NIAID) [E]" < @nih.gov>, "Embry, Alan (NIH/NIAID) [E]" < @niaid.nih.gov> Subject: FW: - Date: Mon, 01 Mar 2021 21:38:21 -0500 Importance: Normal Attachments: ME_DW_FDA_3_1_21_.pdf FYSA I will review with Barney, Karin and Julie at VRC to get some input of what this may mean. From: Fauci, Anthony (NIH/NIAID) [E] < @niaid.nih.gov> Sent: Monday, March 1, 2021 6:07 PM To: Mascola, John (NIH/VRC) [E] < @mail.nih.gov> Cc: Lane, Cliff (NIH/NIAID) [E] < @niaid.nih.gov> Subject: FW: - Let us discuss. Anthony S. Fauci, MD Director National Institute of Allergy and Infectious Diseases National Institutes of Health Bethesda, MD Phone: FAX: E-mail: @niaid.nih.gov The information in this e-mail and any of its attachments is confidential and may contain sensitive information. It should not be used by anyone who is not the original intended recipient. If you have received this e-mail in error please inform the sender and delete it from your mailbox or any other storage devices. The National Institute of Allergy and Infectious Diseases (NIAID) shall not accept liability for any statements made that are the sender's own and not expressly made on behalf of the NIAID by one of its representatives. From: Weissman, Drew < @pennmedicine.upenn.edu> Sent: Monday, March 1, 2021 5:21 PM To: Fauci, Anthony (NIH/NIAID) [E] < @niaid.nih.gov> Subject: Re: - Tony, Here is the human dose IM studies in pregnant mice. We still have some concern over the data and are talking to all of the appropriate people. Congratulations on the Dan David Prize Hope you and your family are doing well.